MedPath

BRUSH Sign: Radiolographic Marker of Cerebral Infarctus Prognosis

Completed
Conditions
Cerebral Infarction
Registration Number
NCT03467269
Lead Sponsor
Fondation Hôpital Saint-Joseph
Brief Summary

Today the treatment of ischemic stroke in acute phase is based on medicinal or endovascular revascularization. Cerebral MRI sequences help the diagnostic. This procedure uses deoxyhemoglobin as an endogenous tracer. This is also a scorer of cerebral ischemia and the increase lets visualized transcerebral veins in the suffering zone giving a brush aspect. Several studies show the interest of this sign and conclude that deoxyhemoglobin presence is a predictive factor of cerebral ischemia. The aim of the study is to evaluate this brush-sign and correlate it with the prognosis retrospectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria
  • age>18 years old
  • hospitalized for cerebral infarction
  • MCA territory
  • MRI within 24hours
  • Sequence of magnetic susceptibility (SWAN)
Exclusion Criteria
  • Incomplete cerebral infarct
  • MRI not possible

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
autonomy levelMonth 3

measurement of autonomy level by mRS

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Groupe Hospitalier Paris Saint Joseph

🇫🇷

Paris, Ile-de-France, France

© Copyright 2025. All Rights Reserved by MedPath